Kyntra Bio Appointed New Board Member
Andrew E. Singer joined the Kyntra Bio Board of Directors on October 1, replacing Maykin Ho.
Updated on Oct. 1, 2026 in People
Kyntra Bio announced a transition on its governing board this week. Andrew E. Singer has been appointed to the Board of Directors and Audit Committee, following the departure of longtime member Maykin Ho.
Why it matters
The board oversees key strategic and financial decisions for the San Francisco-based firm. These leadership shifts reflect the changing makeup of the company's governance as it manages its long-term operations.
Andrew E. Singer brings 25 years of experience to the board, including overseeing $50 billion in transactions. This change follows the departure of Maykin Ho, who served for eight years.
The players
Andrew E. Singer
He is the current CEO of Fika Bio Consulting and a new member of the Kyntra Bio Board of Directors.
Maykin Ho
She is a departing board member who served on the Kyntra Bio board for eight years.
Kyntra Bio
This is a San Francisco-based company that announced recent changes to its leadership structure.
The details
Andrew E. Singer, who currently serves as CEO of Fika Bio Consulting, joined the board effective October 1, 2026. Prior to his current role, Singer held positions at Credit Suisse, Wells Fargo, and RBC Capital Markets. His predecessor, Maykin Ho, officially stepped down from the board on September 30, 2026.
Timeline
September 30, 2026: Maykin Ho stepped down from the Board of Directors.
October 1, 2026: Andrew E. Singer joined the Board of Directors.
Across the Bay
This appointment follows a local industry pattern of shifting board seats to bring in senior financial advisors from major institutions. The move mirrors the 2024 leadership restructuring at Vir Biotechnology, where firms adjust board composition to integrate new industry expertise.
This transition changes the oversight team at the San Francisco-based Kyntra Bio. Residents and stakeholders should watch for upcoming corporate disclosures to understand how the new board alignment affects the company's local business footprint.
The takeaway
Board transitions are a primary signal of a company's strategic pivot. Keep an eye on future company filings to see how the addition of Singer's financial experience influences the firm's direction.
Further reading
You can track ongoing executive and board changes in the local biotech sector on our People page.
